FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048490035> ?p ?o ?g. }

• W2048490035 endingPage "1083" @default.
• W2048490035 startingPage "1076" @default.
• W2048490035 abstract "Hypoxic tumor cells are resistant to radiotherapy and various chemotherapeutic agents. The pretherapeutic assessment of intratumoral hypoxia may allow selection of patients for intensified treatment regimens. Carbonic anhydrase IX (CAIX) is an endogenous hypoxia-related protein involved in pH regulation and is upregulated in many tumor types. Radionuclide imaging using a monoclonal antibody against CAIX, such as cG250, may allow noninvasive PET of hypoxia in these tumor types. The aims of this study were to investigate whether ⁸⁹Zr-labeled cG250-F(ab′)₂ allowed visualization of tumor hypoxia using small-animal PET and whether the tracer showed spatial correlation to the microscopic distribution of CAIX-expressing cells in a human head and neck xenograft tumor model. <b>Methods:</b> Athymic mice with subcutaneous human head and neck carcinoma xenografts (SCCNij3) were imaged with small-animal PET after injection of ⁸⁹Zr-cG250-F(ab′)₂. PET images were parameterized in terms of standardized uptake values (SUVs). After injection with the nitroimidazole hypoxia marker pimonidazole and the perfusion marker Hoechst 33342, the animals were sacrificed, tumors excised, and CAIX- and pimonidazole-marked hypoxia and blood perfusion were analyzed immunohistochemically. ⁸⁹Zr-cG250-F(ab′)₂ tumor uptake was analyzed by ex vivo activity counting and by autoradiography of tumor sections. <b>Results:</b> As early as 4 h after administration, accumulation of ⁸⁹Zr-cG250-F(ab′)₂ in the tumor had occurred and tumors were clearly visualized by PET, with reduced uptake by 24 h after injection. Pixel-by-pixel analysis showed a significant positive spatial correlation between CAIX expression and ⁸⁹Zr-cG250-F(ab′)₂ localization (<i>r</i> = 0.57–0.74; <i>P</i> < 0.0001). Also, significant correlations were found between pimonidazole staining intensity and ⁸⁹Zr-cG250-F(ab′)₂ activity concentration, although less strong (<i>r</i> = 0.46–0.68; <i>P</i> < 0.0001). Tumor maximum SUV correlated significantly with tumor uptake determined ex vivo (<i>r</i> = 0.93; <i>P</i> = 0.0067), as did fractions of CAIX and pimonidazole in tumor sections (<i>r</i> = 0.75; <i>P</i> = 0.03 and <i>r</i> = 0.78; <i>P</i> = 0.02, respectively). <b>Conclusion:</b>⁸⁹Zr-labeled cG250-F(ab′)₂ small-animal PET showed rapid accumulation in a head and neck xenograft tumor model with good correlation to CAIX expression on a microscopic level." @default.
• W2048490035 created "2016-06-24" @default.
• W2048490035 creator A5000396669 @default.
• W2048490035 creator A5012052834 @default.
• W2048490035 creator A5012764804 @default.
• W2048490035 creator A5022337881 @default.
• W2048490035 creator A5023112999 @default.
• W2048490035 creator A5032314957 @default.
• W2048490035 creator A5042792515 @default.
• W2048490035 creator A5056620057 @default.
• W2048490035 creator A5068239835 @default.
• W2048490035 creator A5091492738 @default.
• W2048490035 date "2010-06-16" @default.
• W2048490035 modified "2023-09-28" @default.
• W2048490035 title "PET of Hypoxia with ⁸⁹Zr-Labeled cG250-F(ab′)₂ in Head and Neck Tumors" @default.
• W2048490035 cites W1580787673 @default.
• W2048490035 cites W1942004826 @default.
• W2048490035 cites W1992070664 @default.
• W2048490035 cites W1996400431 @default.
• W2048490035 cites W1998676371 @default.
• W2048490035 cites W1999494285 @default.
• W2048490035 cites W2007695861 @default.
• W2048490035 cites W2013624093 @default.
• W2048490035 cites W2019159661 @default.
• W2048490035 cites W2024610123 @default.
• W2048490035 cites W2025767910 @default.
• W2048490035 cites W2027540110 @default.
• W2048490035 cites W2030411023 @default.
• W2048490035 cites W2036753927 @default.
• W2048490035 cites W2058426435 @default.
• W2048490035 cites W2062594348 @default.
• W2048490035 cites W2084650789 @default.
• W2048490035 cites W2093385328 @default.
• W2048490035 cites W2093623701 @default.
• W2048490035 cites W2100438537 @default.
• W2048490035 cites W2104812119 @default.
• W2048490035 cites W2118167053 @default.
• W2048490035 cites W2119216120 @default.
• W2048490035 cites W2125257427 @default.
• W2048490035 cites W2129922868 @default.
• W2048490035 cites W2131938193 @default.
• W2048490035 cites W2147316061 @default.
• W2048490035 cites W2163824159 @default.
• W2048490035 cites W2168966763 @default.
• W2048490035 cites W2170212327 @default.
• W2048490035 cites W2175411730 @default.
• W2048490035 doi "https://doi.org/10.2967/jnumed.109.073189" @default.
• W2048490035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20554724" @default.
• W2048490035 hasPublicationYear "2010" @default.
• W2048490035 type Work @default.
• W2048490035 sameAs 2048490035 @default.
• W2048490035 citedByCount "96" @default.
• W2048490035 countsByYear W20484900352012 @default.
• W2048490035 countsByYear W20484900352013 @default.
• W2048490035 countsByYear W20484900352014 @default.
• W2048490035 countsByYear W20484900352015 @default.
• W2048490035 countsByYear W20484900352016 @default.
• W2048490035 countsByYear W20484900352017 @default.
• W2048490035 countsByYear W20484900352018 @default.
• W2048490035 countsByYear W20484900352019 @default.
• W2048490035 countsByYear W20484900352020 @default.
• W2048490035 countsByYear W20484900352021 @default.
• W2048490035 countsByYear W20484900352022 @default.
• W2048490035 countsByYear W20484900352023 @default.
• W2048490035 crossrefType "journal-article" @default.
• W2048490035 hasAuthorship W2048490035A5000396669 @default.
• W2048490035 hasAuthorship W2048490035A5012052834 @default.
• W2048490035 hasAuthorship W2048490035A5012764804 @default.
• W2048490035 hasAuthorship W2048490035A5022337881 @default.
• W2048490035 hasAuthorship W2048490035A5023112999 @default.
• W2048490035 hasAuthorship W2048490035A5032314957 @default.
• W2048490035 hasAuthorship W2048490035A5042792515 @default.
• W2048490035 hasAuthorship W2048490035A5056620057 @default.
• W2048490035 hasAuthorship W2048490035A5068239835 @default.
• W2048490035 hasAuthorship W2048490035A5091492738 @default.
• W2048490035 hasBestOaLocation W20484900351 @default.
• W2048490035 hasConcept C126322002 @default.
• W2048490035 hasConcept C141071460 @default.
• W2048490035 hasConcept C142724271 @default.
• W2048490035 hasConcept C150903083 @default.
• W2048490035 hasConcept C178790620 @default.
• W2048490035 hasConcept C185592680 @default.
• W2048490035 hasConcept C207001950 @default.
• W2048490035 hasConcept C2779081379 @default.
• W2048490035 hasConcept C2989005 @default.
• W2048490035 hasConcept C3018411727 @default.
• W2048490035 hasConcept C502942594 @default.
• W2048490035 hasConcept C509974204 @default.
• W2048490035 hasConcept C540031477 @default.
• W2048490035 hasConcept C71924100 @default.
• W2048490035 hasConcept C7836513 @default.
• W2048490035 hasConcept C86803240 @default.
• W2048490035 hasConceptScore W2048490035C126322002 @default.
• W2048490035 hasConceptScore W2048490035C141071460 @default.
• W2048490035 hasConceptScore W2048490035C142724271 @default.
• W2048490035 hasConceptScore W2048490035C150903083 @default.
• W2048490035 hasConceptScore W2048490035C178790620 @default.
• W2048490035 hasConceptScore W2048490035C185592680 @default.

• next